Navigation Links
Mlu I from New England Biolabs

ProductsMlu I from New England Biolabs
Company New England Biolabs
Item Mlu I
Price $55.00
Description 
Info New England BiolabsNew England Biolabs
32 Tozer Rd.
Beverly, MA 01915-5599

Customer Service: 800-632-5227
Tech Support: 800-632-7799
Fax Number: 978-921-1350
Web Site: http://www.neb.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Ph.D. Peptide Display Cloning System from New England Biolabs
2. IMPACT-CN System from New England Biolabs
3. T4 DNA Polymerase from New England Biolabs
4. Mung Bean Nuclease from New England Biolabs
5. ShortCut RNase III from New England Biolabs
6. DNA Polymerase I Large (Klenow) Fragment from New England Biolabs
7. Lambda Protein Phosphatase from New England Biolabs
8. Lambda Protein Phosphatase from New England Biolabs
9. Afe I from New England Biolabs
10. Acl I (Psp1406 I) from New England Biolabs
11. BamH I from New England Biolabs
Anti-Human I-FABP Polyclonal Antibody, Unconjugated from Cell Sciences
ProPrep BAC 960 from Biotech Support Group
ProPrep BAC 960 from Biotech Support Group
Chicken Anti-Plants Thaumatin 2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products:
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How to read brain activity? 2New therapy targets for amyloid disease 2Uninsured Issue Takes Center Stage This Weekend in New Orleans 61155 1Natural and Organic Consumers Focus on Health and Wellness Amidst Public Health Concerns 61152 1Natural and Organic Consumers Focus on Health and Wellness Amidst Public Health Concerns 61152 2China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 1China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 2China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 3
... Minnesota Medical School and Brain Sciences Cente...fied a noninvasive and painless way to diagnose co... at a point of light., The research offers promise...gnosis for brain diseases, as well as a way to mea... these diseases.,Using magnetoencephalography (MEG...
...al Society (ACS) News Service Weekly Press Package...rom scientific presentations scheduled for the ACS...erage of reports from ACS 36 major peer-reviewed j...e with the Aug. 29, 2007 edition. , , ACS NEWS ...OR VARIOUS TIMES AS INDICATED , PressPac Archive:...
...r, younger looking skin, scientists from the Unive...ave made an important discovery toward manipulatin...search range from helping doctors develop more nat...cosmetics companies develop new products for achie...published in the September print issue of The FASE...
Other Biology News:U of MN researchers discover noninvasive diagnostic tool for brain diseases 2American Chemical Society's Weekly PressPac -- Aug. 15, 2007 2American Chemical Society's Weekly PressPac -- Aug. 15, 2007 3American Chemical Society's Weekly PressPac -- Aug. 15, 2007 4American Chemical Society's Weekly PressPac -- Aug. 15, 2007 5American Chemical Society's Weekly PressPac -- Aug. 15, 2007 6American Chemical Society's Weekly PressPac -- Aug. 15, 2007 7American Chemical Society's Weekly PressPac -- Aug. 15, 2007 8American Chemical Society's Weekly PressPac -- Aug. 15, 2007 9American Chemical Society's Weekly PressPac -- Aug. 15, 2007 10American Chemical Society's Weekly PressPac -- Aug. 15, 2007 11American Chemical Society's Weekly PressPac -- Aug. 15, 2007 12American Chemical Society's Weekly PressPac -- Aug. 15, 2007 13Scientists discover important beauty secret for balanced skin color and tone 2
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3